key: cord-0903088-rugo991s
authors: Rajput, Sandeep K.; Logsdon, Deirdre M.; Kile, Becca; Engelhorn, Heidi J.; Goheen, Ben; Khan, Shaihla; Swain, Jason; McCormick, Sue; Schoolcraft, William B.; Yuan, Ye; Krisher, Rebecca L.
title: Human eggs, zygotes, and embryos express the receptor ACE2 and protease TMPRSS2 protein necessary for SARS-CoV-2 infection
date: 2020-12-24
journal: F S Sci
DOI: 10.1016/j.xfss.2020.12.005
sha: 40487256fc6cb5768b52502c315ba557234ece45
doc_id: 903088
cord_uid: rugo991s

Objective To study mRNA and protein expression of SARS-CoV-2 entry receptors (ACE2, CD147) and proteases (TMPRSS2, CTSL) in human oocytes, embryos, cumulus and granulosa cells. Design Research Study. Setting Clinical IVF treatment center Patient(s) IVF patients treated at the Colorado Center for Reproductive Medicine. Intervention(s) Oocytes (GV, MII) and embryos (1 cell (1C); blastocyst (BL)) were donated to research at disposition by IVF patients. Follicular cells (cumulus (CC); granulosa (GC)) were collected from women undergoing egg retrieval after ovarian stimulation without an ovulatory trigger for IVM/IVF treatment cycles Main Outcome Measure(s) The presence or absence of ACE2, CD147, TMPRSS2, and CTSL mRNA using RT-qPCR and protein using capillary Western blotting in human oocytes, embryos and ovarian follicular cells. Result (s) RT- q-PCR analysis revealed high abundance of ACE2 gene transcripts in GV and MII oocytes compared to CC, GC, and BL. ACE2 protein was only present in MII oocytes, 1C, and BL embryos, but other ACE2 protein variants were observed in all the samples. TMPRSS2 protein was present in all samples while mRNA was observed only at the blastocyst stage. All the samples were positive for CD147 and CTSL mRNA expression. However, cumulus and granulosa cells were the only samples that showed co-expression of both CD147 and CTSL proteins in low abundance. Conclusion(s) Cumulus and granulosa cells are least susceptible to SARS-CoV-2 infection due to the lack of required receptors and proteases combination (ACE2/TMPRSS2 or CD147/CTSL) in high abundance. Co-expression of the ACE2 and TMPRSS2 proteins in MII oocytes, zygotes, and blastocysts demonstrate that these gametes and embryos have the cellular machinery required and thus are potentially susceptible to SARS-CoV-2 infection if exposed to the virus. However, we do not yet know if infection occurs in vivo, or in vitro in an ART setting.

Since the description of a novel coronavirus in Wuhan, China in late 2019, the virus, now called 64 Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has spread around the globe 65 affecting 188 countries. Over 30 million people have been infected worldwide, and nearly 1 66 million people have died due to COVID19, the disease caused by SARS-CoV-2 (1). Initially, as 67 countries rapidly shut down to control the spread of the novel coronavirus and avoid 68 overburdening healthcare systems, assisted reproduction was also curtailed, being classified in 69 most instances as non-essential. Very little was known about the potential for infection of sperm, 70 eggs, or embryos, the potential for sexual transmission between partners, vertical transmission 71 between a mother and conceptus, or possible effects of maternal infection on the early embryo 72 and fetus. This lack of information led to great concern in the field about how the virus might 73 potentially impact laboratory and pregnancy outcomes in IVF, in addition to speculation about 74 potential changes in standard operating procedures in an IVF laboratory during a pandemic (2, 75 3). 76 As the pandemic continued, the impact on couples desiring treatment grew. Specific groups of 77 infertile patients faced significantly reduced prognoses if their treatment continued to be delayed 78 (4). However, the unknown effects of SARS-CoV-2 on reproduction made it difficult to 79 determine best IVF laboratory practices necessary to mitigate the risks of contamination and 80 infection to both patients and staff. For example, current IVF practice often involves breaching 81 the zona pellucida for biopsy and genetic testing, presenting a potential opportunity for the virus 82 to gain access to embryonic cells both during preimplantation culture and cryostorage. It is 83 therefore of great importance that we advance our understanding of the potential for infection by 84 SARS-CoV-2 in gametes and embryos.

The role of proteins associated with SARS-CoV-2 host cell entry is outlined in Figure 1 . 86 Although understanding of the molecular mechanism of viral entry continues to be refined, the 87 described mechanism involves viral spike (S) protein mediated recognition and binding to the 88 host cell receptor angiotensin 1 converting enzyme 2 (ACE2), after which the protease 89 transmembrane serine protease 2 (TMPRSS2) cleaves the spike protein to facilitate cell entry (5). 90 ACE2, a negative regulator of the renin-angiotensin system, has multiple physiological functions 91 and is widely expressed throughout the body (6). The S protein cleavage site in SARS-CoV-2 is 92 identical to SARS-CoV, which is also known to take advantage of the endosomal cysteine 93 protease Cathepsin L (CTSL) to cleave specific peptide bonds and facilitate the fusion of viral 94 and host cell membranes and the release of the viral genome into the host cell cytoplasm (7, 8) . 95 An alternative ACE2 independent mechanism, with basigin (BSG, or CD147) as the cellular 96 receptor and CTSL as the protease may also mediate SARS-CoV-2 cell entry. Theoretically, 97 tissues and cells that contain these receptors and proteases, particularly high co-expression of 98 ACE2 and TMPRSS2, are more vulnerable to infection by SARS-CoV-2. 99 Scientifically, information has continued to emerge that impacts the clinical application of 100 assisted reproductive technologies (ART). One popular method to provide needed information 101 quickly has been to query existing transcriptomic databases for the presence of the receptors and 102 proteases necessary for SARS-CoV-2 infection of host cells. The SARS-CoV-2 receptor ACE2 potential for infection of the ovary and oocyte. The possibility remains that SARS-CoV-2 might 109 affect female fertility by infecting ovarian granulosa cells and/or the oocyte directly, thereby 110 negatively impacting ovarian function and reducing oocyte quality (12). Analysis of existing 111 single cell RNA sequencing (scRNASeq) datasets also revealed the presence of transcripts for 112 SARS-CoV-2 related genes, including the receptors ACE2 and BSG, and the proteases 113 TMPRSS2 and CTSL, in human embryos (13), suggesting that they may have the potential to be 114 infected by SARS-CoV-2 as well. The fallopian tube expresses ACE2 in a small number of cells, 115 but the protease TMPRSS2 was widely expressed in different cell types although again there was 116 no detectable co-expression of ACE2 and TMPRSS2 (11), suggesting that the site of fertilization 117 and early embryonic development is unlikely to be infected. In the uterus, ACE2 is expressed at 118 a low level but TMPRSS2 expression is absent, again suggesting that infection is unlikely (11).

In peri-and post-implantation stage human embryos, transcripts for ACE2 and TMPRSS2 are 120 co-expressed in day 6 and day 7 trophoblast, day 12 and day 14 syncytiotrophoblast, and some 121 hypoblast cells; TMPRSS2 alone is expressed in the epiblast (14). BSG and CTSL transcripts are 122 expressed in all cell types at this stage (14). Again, this suggests the susceptibility of the human 123 embryo to SARS-CoV-2 infection and potential implications for implantation and pregnancy, as 124 well as the potential transmission of the virus from mother to fetus through the placenta.

However, transcript levels often do not accurately reflect protein abundance, and this has been 126 demonstrated for ACE2 as well (15). In fact, when comparing publically available proteomic and 127 transcriptomic databases, ACE2 protein is abundant in the ovary despite its low mRNA levels 128 (15). This is not terribly surprising, as processes including post-transcriptional, translational, and 129 protein degradation occur after mRNA is transcribed, leading to differences between mRNA 130 levels and protein abundance of as much as 15-70% (16, 17) . Protein expression analyses in 131 J o u r n a l P r e -p r o o f oocytes, embryos and follicular cells has relied on immunohistochemistry (IHC) due to the 132 scarcity of human sample availability. In addition to the potential for false positive results due to 133 antibody cross-reactivity to similar proteins, IHC has been recognized for false negative results 134 since its inception (18) (19) (20) (21) . A recent study (22) reported that IHC failed to detect ACE2 protein 135 expression in either follicular or stromal ovarian cells, but high expression of ACE2 protein was 136 found by mass spectrometry. Western blot is a gold standard technique to study protein 137 expression, as it reveals the molecular mass of the protein along with its expression level.

However, application of Western blot to the analysis of oocyte and embryo protein expression 139 has been limited, as it requires a large number of samples (23, 24) . In this study, we used a high 140 sensitivity capillary Western blot approach (ProteinSimple TM ), which was further optimized in 141 our laboratory to detect up to 10 proteins from a pool of 10 oocytes or embryos.

The objective of this work was to characterize the presence or absence of four proteins, ACE2, 143 BSG (CD147), TMPRSS2, and CTSL, important for SARS-CoV-2 infection, in human follicular 144 cells, mature oocytes, zygotes, and blastocysts. Our data demonstrates that these proteins are 145 present in these tissues. Of interest, ACE2 and TMPRSS2 protein are both present in high 146 abundance in mature oocytes, zygotes, and blastocysts. This work demonstrates that human 147 oocytes and embryos have the necessary machinery to be infected with SARS-CoV-2 if they 148 were to be exposed, either in vivo or in the laboratory. This information is important for IVF 149 clinics as they work to safely provide infertility treatment during the global pandemic. Table S1 . For qPCR, a total of 2 ul of diluted cDNA was used in a reaction 202 mixture (25ul) containing 2X Sso Advanced™ SYBR® green (Bio-Rad) master mix, 5 203 picomoles of each gene specific forward and reverse primers, and nuclease free water. Reaction 204 mixtures were divided in half (12.5 ul) to prepare two technical replicates per sample and 205 subjected for qPCR amplification at 95°C for 10 minutes for initial denaturation followed by 45 206 cycles of 95°C denaturation for 15 seconds and an annealing/extension step at 60°C for 1min.

For each reaction product, a post amplification melt curve analysis was performed to ensure a 208 single and specific amplicon. The relative abundance of endogenous GAPDH was used as an 209 internal control for each sample and qPCR data was analyzed using the 2 −ΔΔCt method. MWs compared to that of reported variants of these proteins (Table S3) . Mature oocytes and embryos lack basigin (CD147) protein 300 We observed significantly higher CD147 mRNA expression in immature oocytes compared to 301 MII oocytes, BL embryos, CC, and GC ( Figure 4A ). CD147 is an N-linked glycosylated protein 302 and contains multiple glycosylation sites, which results in its migration between 43 kD to 66 kD 303 MW in Western blot analysis (30). Our results demonstrate the presence of a glycosylated 304 CD147 (60 kDa) protein which was significantly higher (p<0.05) in granulosa cells compared to 305 cumulus cells, and is completely undetected in oocytes or embryos (Figure 4 B, C) . 

An interactive web-based dashboard to track COVID-19 in real time

COVID-19 and fertility: a virtual reality

A recommendation for IVF lab practice in light of the current COVID-19 pandemic

COVID-19 and assisted 458 reproductive technology services: repercussions for patients and proposal for individualized clinical 459 management

Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th 465 Anniversary of the Discovery of ACE2

Inhibitors of cathepsin 467 L prevent severe acute respiratory syndrome coronavirus entry

Identification of a broad-470 spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola

Nipah viruses by using a novel high-throughput screening assay

/ACE2 on the female reproductive system

Female reproductive tract has low concentration of SARS-CoV2 477 receptors

Potential risks of SARS-CoV-2 infection on 479 reproductive health

A single-cell RNA expression map 481 of coronavirus receptors and associated factors in developing human embryos

Expression of SARS-CoV-2 receptor ACE2 and 484 the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester

A comprehensive investigation of the mRNA 487 and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells

Global signatures of protein and mRNA 490 expression levels

Insights into the regulation of protein abundance from proteomic and 492 transcriptomic analyses

Reflections on the use of controls in 494 immunohistochemistry and proposal for application of a multitissue spring-roll control block

Pitfalls in diagnostic immunohistology

American Society of 498 Clinical Oncology/College Of American Pathologists guideline recommendations for 499 immunohistochemical testing of estrogen and progesterone receptors in breast cancer

In situ molecular pathology and co-expression analyses

Coronavirus disease-19 and fertility: viral host entry 504 protein expression in male and female reproductive tissues

Role of bone morphogenetic protein 506 signaling in bovine early embryonic development and stage specific embryotropic actions of 507 follistatindagger

Pre-and Peri-/Post-Compaction 509

Follistatin Treatment Increases In Vitro Production of Cattle Embryos

Intracellular cathepsin C 511 levels determine sensitivity of cells to leucyl-leucine methyl ester-triggered apoptosis

ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, 513 hypertension, multi-organ failure, and COVID-19 disease outcome

Novel Variants of Angiotensin Converting Enzyme-2 of Shorter 516 Molecular Size to Target the Kidney Renin Angiotensin System

Characterization of Angiotensin Converting Enzyme-518 2 (ACE2) in Human Urine

Alternative splicing of ACE2 possibly generates variants that may limit the 520 entry of SARS-CoV-2: a potential therapeutic approach using SSOs

Importance of N-glycosylation on CD147 for its 522 biological functions

Characterization of basigin isoforms and 524 the inhibitory function of basigin-3 in human hepatocellular carcinoma proliferation and invasion

A new nuclear 527 protease with cathepsin L properties is present in HeLa and Caco-2 cells

Gene expression during the oocyte-to-embryo transition in 530 mammals

A human homolog of angiotensin-532 converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

The heterogeneous nature of the Coronavirus receptor, angiotensin-535 converting enzyme 2 (ACE2) in differentiating airway epithelia

A novel isoform of 537 <em>ACE2</em> is expressed in human nasal and bronchial respiratory epithelia and is upregulated in 538 response to RNA respiratory virus infection

Soluble angiotensin-converting enzyme 2: a potential approach 540 for coronavirus infection therapy

Transient expression of 542 progesterone receptor and cathepsin-l in human granulosa cells during the periovulatory period

No evidence of severe acute respiratory 545 syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019

SARS-CoV-2 entry factors 548 are highly expressed in nasal epithelial cells together with innate immune genes

ACE2 Receptor Expression in Testes: Implications in 551 COVID-19 Pathogenesis

Absence of 2019 novel coronavirus in semen and 553 testes of COVID-19 paLents †

Clinical Characteristics and Results of Semen Tests Among 555

Men With Coronavirus Disease

SARS-CoV-2 testing in infertile patients: different recommendations in 557 Europe and America

Prior and novel coronaviruses

COVID-19), and human reproduction: what is known?

Cryopreservation in reproductive medicine during 562 the COVID-19 pandemic: rethinking policies and European safety regulations

Cryopreservation and IVF in the time of Covid-19: what is the best 565 good tissue practice (GTP)?

Managing the IVF 567 laboratory during a pandemic: international perspectives from laboratory managers

Delay in IVF treatment up to 180 days 570 does not affect pregnancy outcomes in women with diminished ovarian reserve

Capillary western blot of total TMPRSS2 protein (54 kD) expression and (C) fold change in the 606 TMPRSS2 protein abundance in MII-stage oocytes, 1-cell (1C) and BL stage embryos and in 607 CC and GC (n = 3). Arrow indicates the target protein.TMPRSS2 protein expression was 608 normalized to the total protein present in each samples and data was presented as average protein 609 fold-change from 3 experiments. All bar graphs show the mean ± SEM. Different letters above 610 the bars in graph indicate statistical difference (P < 0.05) determined by one-way ANOVA 611

Expression of CD147 mRNA and protein in human oocytes, embryos and 614 follicular cells. (A) RT-qPCR analysis of CD147 mRNA in GV-and MII-stage oocytes, 615 blastocyst (BL) (n= 3 pools of 6 oocytes or embryos), cumulus cells (CC), and granulosa cells 616 (GC) (n = 3). Expression data was normalized to GAPDH and presented as a bar graph

Capillary western blot of total CD147 protein (60 kD) expression and (C) fold change in the 618 CD147 protein abundance in MII-stage oocytes, 1-cell (1C) and BL stage embryos, and in CC 619 and GC (n = 3 replicates). Arrow indicates the target protein. All bar graphs show the 620 mean ±SEM. Different letters indicate statistical difference (P < 0.05), determined by one-way 621 ANOVA followed by Tukey's test

Cathepsin-L (CTSL) mRNA and protein expression in human oocytes, embryos 624 and follicular cells. (A) CTSL mRNA expression analyzed by RT-qPCR at GV-and MII-stage 625

cumulus cells (CC), and 626 granulosa cells (GC) (n = 3). Expression data was normalized to GAPDH and presented as a bar 627 graph. (B) Capillary western blot of total CTSL protein expression and (C)